FE Cotté
Bristol-Myers Squibb (France) · 70 works · 221 citations · h-index 5
Top works
- Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
- 1276P Nivolumab treatment in advanced non-small cell lung cancer (aNSCLC): Real-world 3-year outcomes within overall and special populations (the UNIVOC study)
- Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women
- A Markov Model Simulation of the Impact of Treatment Persistence in Postmenopausal Osteoporosis
- Health-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study
- Management of lung cancer patients' quality of life in clinical practice: a Delphi study
- Access to Innovative Drugs in Patients with Metastatic Lung Cancer in French Public Hospitals (the Territoire Study)
- Anticoagulation Treatment with VKA in France, Italy, Germany, Spain and United Kingdom. Results from the React AF Study
- 101P Nivolumab outcomes in interstitial lung disease patients with advanced non-small cell lung cancer in French real-world setting
- Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: Updated survival and subgroup analysis from the real-world EVIDENS study
- Clinical benefit of anti-PD-(L)1 immunotherapies in advanced cancer in France: a population-based estimate from 2014 to 2021
- Utilisation des inhibiteurs de checkpoint (ICI) en hospitalisation à domicile (HAD) pour les patients atteints d'un cancer en France en 2020 : analyse descriptive des données du PMSI
- Utilisation de l'Echantillon généraliste des bénéficiaires (EGB) pour décrire les modalités de prescription des traitements Immunosuppresseurs (IS) chez les transplantés rénaux en France
- PCN466 HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN CLINICAL PRACTICE FOR IMMUNE-CHECKPOINT INHIBITORS (ICI)-TREATED PATIENTS: WHAT ARE PATIENTS' EXPERIENCES AND EXPECTATIONS? RESULTS FROM AN ONLINE PATIENT COMMUNITY RESEARCH
- EE520 Hospital Costs in Resected Patients With Early-Stage Non-Small Cell Lung Cancer (NSCLC): A French Real-World Retrospective Study Based on the National Hospitalization Database (PMSI)
- PCN464 HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF CANCER PATIENTS TREATED WITH IMMUNOTHERAPY: USE OF SOCIAL MEDIA IN FRENCH LANGUAGE TO EXPLORE RELEVANCE OF CONCEPTS COVERED BY CANCER GENERIC HRQOL MEASURES
- EPH186 Public Health Impact of Immunotherapies in Advanced Cancers in France: A National Retrospective Estimate Until End of 2020
- Adherence to Treatment and Persistency in Patients Treated with VKA in France, Italy, Germany, Spain and the United Kingdom
- Gender differences in the management of antithrombotic prescriptions among patients with atrial fibrillation by general practitioners in France
- Nivolumab treatment in advanced non-small cell lung cancer (aNSCLC): A French nationwide retrospective cohort (UNIVOC Study)